Showing results (241-250 of 411) with videos related to

Sort By:
Pageof 42
Blood|December 7, 2011
FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphomaYussanne P Ma, Flora E van Leeuwen, Rosie Cooke, et al.
Science (New York, N.Y.)|April 4, 2024
De novo design of drug-binding proteins with predictable binding energy and specificityLei Lu, Xuxu Gou, Sophia K Tan, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
De novo design of drug-binding proteins with predictable binding energy and specificityLei Lu, Xuxu Gou, Sophia K Tan, et al.
Breast Cancer Research and Treatment|April 22, 2011
Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biologyFelipe C Geyer, Dario de Biase, Maryou B K Lambros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Perilobar nephrogenic rests are nonobligate molecular genetic precursor lesions of insulin-like growth factor-II-associated Wilms tumorsRaisa Vuononvirta, Neil J Sebire, Anthony R Dallosso, et al.
Cancer Research|February 25, 2010
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancerNicholas Turner, Alex Pearson, Rachel Sharpe, et al.
Breast Cancer Research and Treatment|August 19, 2009
An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancersRachael Natrajan, Britta Weigelt, Alan Mackay, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 15, 2010
PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization studyMaryou B Lambros, Rachael Natrajan, Felipe C Geyer, et al.
Bioorganic Chemistry|September 13, 2025
Structure-activity relationship studies on 2-thienylidene substituted 3-oxo-2,3-dihydrobenzofuran-7-carboxamides as poly (ADP-ribose) polymerase inhibitorsAbosede Salami, Ugochi Adiele, Griffin Coate, et al.
Human Molecular Genetics|March 8, 2007
Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibilityNichola Johnson, Olivia Fletcher, Claire Palles, et al.
Pageof 42